Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  Genscript Biotech Corporation    1548   KYG3825B1059

GENSCRIPT BIOTECH CORPORATION

(1548)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Genscript Biotech : LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

share with twitter share with LinkedIn share with facebook
08/02/2020 | 07:56am EDT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Genscript Biotech Corporation

金斯瑞生物科技股份有限公司 *

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 1548)

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

The members of the board of directors (the "Board") of Genscript Biotech Corporation (the "Company") are set out below:

Executive Directors

Ms. WANG Ye (President)

Mr. MENG Jiange (Secretary of the Board)

Non-Executive Directors

Dr. ZHANG Fangliang (Chairman)

Dr. WANG Luquan

Mr. PAN Yuexin

Ms. WANG Jiafen

Independent Non-Executive Directors

Mr. GUO Hongxin

Mr. DAI Zumian

Mr. PAN Jiuan

1

The Board has established three committees, and the directors of the Company are serving on the respective committees as below:

Board

Committee

Remuneration

Nomination

Director

Audit Committee

Committee

Committee

Dr. ZHANG Fangliang

/

/

C

Ms. WANG Ye

/

M

/

Mr. GUO Hongxin

M

C

/

Mr. DAI Zumian

C

M

M

Mr. PAN Jiuan

M

/

M

Notes:

  1. Chairman of the relevant Board committees
  1. Member of the relevant Board committees

Hong Kong, 2 August 2020

*  For identification purposes only

2

Disclaimer

GenScript Biotech Corporation published this content on 02 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 August 2020 11:56:01 UTC

share with twitter share with LinkedIn share with facebook
Toute l'actualité sur GENSCRIPT BIOTECH CORPORAT
08/11BERONI GROUP LIMITED (NSX : BTG) Signs Agreement with Genscript Biotech
AQ
08/05GENSCRIPT BIOTECH : Voluntary announcement-research and development update
PU
08/02Legend names founder Frank Zhang as chief executive officer
RE
08/02GENSCRIPT BIOTECH : List of directors and their role and function
PU
08/02GENSCRIPT BIOTECH : Change of chief executive officer and redesignation of direc..
PU
07/23GENSCRIPT BIOTECH : Announces Publication of Clinical Data On New Method for Det..
PR
07/23GENSCRIPT BIOTECH : TRANSFER OF DISTRIBUTION ADSs AND DESPATCH OF CHEQUES FOR CA..
PU
05/29Legend Biotech Sets IPO at 18.4 Million ADSs; Sees Pricing at $18-$20 Each
DJ
05/14GENSCRIPT BIOTECH : Duke-NUS, GenScript and A*STAR launch first-in-the-world SAR..
AQ
04/07GENSCRIPT PROBIO : and Eutilex Enter into Exclusive Strategic Collaboration on P..
PR
More news
Financials (USD)
Sales 2020 326 M - -
Net income 2020 -167 M - -
Net Debt 2020 - - -
P/E ratio 2020 -178x
Yield 2020 -
Capitalization 29 612 M 3 821 M -
Capi. / Sales 2020 90,8x
Capi. / Sales 2021 67,8x
Nbr of Employees 3 738
Free-Float 54,4%
Chart GENSCRIPT BIOTECH CORPORATION
Duration : Period :
Genscript Biotech Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENSCRIPT BIOTECH CORPORAT
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 2,87 $
Last Close Price 15,42 $
Spread / Highest target -79,7%
Spread / Average Target -81,4%
Spread / Lowest Target -83,3%
EPS Revisions
Managers
NameTitle
Zhenyu Liu Chief Executive Officer
Ye Wang President, COO & Executive Director
Fang Liang Zhang Non-Executive Chairman
Jian Ge Meng Executive Director & VP-Investor Relations
Lu Quan Wang Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORPORATION-12.88%3 851
EXACT SCIENCES CORPORATION-5.71%13 087
GUARDANT HEALTH, INC.14.44%8 626
SEEGENE INC--.--%6 007
ADAPTIVE BIOTECHNOLOGIES CORPORATION32.02%5 209
IOVANCE BIOTHERAPEUTICS, INC.3.54%4 138